4th Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for BIOFLORIDA, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 21, 2025 $20,000 Replaced
4th Quarter - Amendment Mar 6, 2025 $20,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL ESTUPINAN (NAME ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

LobbyistCovered position, as disclosed
SOPHIA ESTUPINAN —
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.